HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment vs LIC Healthcare Fund - Direct Plan - Growth
NAV, returns and costs — not a recommendation.
 HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment |  LIC Healthcare Fund - Direct Plan - Growth | |
|---|---|---|
| NAV | ₹22.3 | ₹37.4718 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +25.46% | +15.88% |
| 3 year (p.a.) | +32.38% | +22.43% |
| 5 year (p.a.) | +32.38% | +13.39% |
| Expense ratio | 0.92% | 0.96% |
| Fund size | ₹2362.44 Cr | ₹92.55 Cr |
| Risk | — | Very high |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.